LeanLife Announces Additional Strategic Agreement to Boost Product Sales for Mike Tyson Branded Iron Energy Drink
LeanLife Health Inc. (CSE:LLP)(FSE:LL1)(OTC PINK:LNLHF) (the “Company”) is pleased to announce that it has entered into a significant sales agreement in the United States with Eclypse LLC (“Eclypse”), a private U.S. company specializing in the in the beverage space.
The key principal of Eclypse, Cathal O’Flaherty, has a stellar track record of building and growing beverage brands, including over 16 years at Constellation Brands, where he helped develop sales and business development programs enabling Constellation to enjoy unparalleded growth in the beer industry; accounting for over half the U.S. total sales of imported beer. O’Flaherty worked with iconic brands like Corona Extra and Modelo Especial. During this time the import beer division gew from from $1 billion to $5 billion in revenue. Prior to Constellation, O’Flaherty spent 15 years with Anheuser Busch’s wholesale operations division, working in a wide variety of sales, marketing and operations roles. More recently, O’Flaherty partnered closely with Invest Northern Ireland (NI), the Vermont Cider Company and Vitani Spirits.
To further incent Eclypse, the Company is providing milestone bonuses upon reaching sales of USD $10 MM and USD $20 MM of the Mike Tyson branded Iron Energy drink
Stan Lis, CEO and Director of LeanLife, states: “The Company continues to build a solid foundation by working solely with major distributors and agents who have a track record of building and growing sales in the beverage sector. I am very pleased to add to our roster of sales agents a company whose executive has helped make Corona one of the best-selling beers in the United States. I look forward to working closely with them to facilitate an aggressive sales roll-out across America in 2021.”
About LeanLife Health and its Brand Positioning in the Marketplace
FoodCare Group, the supplier and manufacturer of Iron Energy, by Mike Tyson, is a market leader in Poland’s energy drink market and is a leading brand in the Middle East. We believe, Iron Energy will also appeal to North American consumers and will quickly gain retail and consumer acceptance and trial.
The annual market value of the combined U.S. and Canadian energy drink markets is estimated at over $14 billion (USD). Red Bull is the market leader, followed by Monster and Bang. While Red Bull pursues a premium price strategy; LeanLife will be aggressively priced and shelf positioned, apprealing to a broad consumer base. According to Allied Market Research, the Compound Annual Growth Rate (CAGR) of the global energy drink market is 7.2% while the US market is positioned to grow to over $86 billion (USD) by 2026.
Consumer preference and the increased occasions for energy drink consumption are growing the category. Iron Energy will participate in this phenomenon through category and organic growth. The broad base of young adult consumers will be attracted to this unique product alternative. Iron Energy is enjoying great success in the European market. We believe Iron Energy will offer a similar success story in North America due to its compelling brand attributes, product taste and energy benefits.
For more information, please contact:
Stan Lis, CEO
604-764-0518
SLis@LeanLifeHealth.com
Forward-Looking Information
Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control including, the Company’s ability to compete with large food companies; sales of any potential products developed will be profitable; the ability to complete sales under the sales agreement. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information.
THE CSE HAS NEITHER APPROVED NOR DISAPPROVED THE INFORMATION CONTAINED HEREIN AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
SOURCE: LeanLIfe Health Inc.
